The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Share News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.639%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 61.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tissue Regenix Shares Slump After GBP15 Million Fundraise

Fri, 22nd May 2020 12:16

(Alliance News) - Tissue Regenix Group PLC on Friday said it has raised proceeds of GBP14.6 million via a placing and subscription, the overall size of the fundraise increased due to "significant excess demand".

The medical technology firm raised the funds via a placing and subscription of 5.85 billion shares at a price of 0.25 pence each. The stock closed at 0.975p on Thursday.

Tissue Regenix shares were 53% lower at 0.465p in London on Friday.

The firm on Thursday had said it planned to issue 4.80 billion shares to raise GBP12 million.

"We are extremely pleased with the support shown by both new and existing investors as part of this fundraise. We continue to experience strong demand for our products. This injection of additional capital will allow for the commencement of the planned manufacturing capacity expansion in the US enabling us to increase the output of our San Antonio facility, unlock additional revenues and realise new partnership opportunities we foresee potentially emerging," said Interim Chief Executive Gareth Jones.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Nov 2019 10:32

Tissue Regenix Upbeat On Lender Deal On Loan Covenant Breach Forecast

Tissue Regenix Upbeat On Lender Deal On Loan Covenant Breach Forecast

Read more
17 Oct 2019 09:43

Tissue Regenix Expects Sales Disappointment Amid Output Boost Delay

Tissue Regenix Expects Sales Disappointment Amid Output Boost Delay

Read more
17 Oct 2019 08:03

Tissue Regenix warns of lower revenues and EBITDA

(Sharecast News) - Regenerative medical devices group Tissue Regenix warned on Thursday that full-year revenues would be roughly 15-20% lower than anticipated after a delay in bringing increased manufacturing capabilities onstream.

Read more
3 Oct 2019 11:48

Tissue Regenix Extends DermaPure Product Line For Surgical Markets

Tissue Regenix Extends DermaPure Product Line For Surgical Markets

Read more
3 Oct 2019 08:29

Tissue Regenix extends dCELL technology with new DermaPure product

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group announced the launch of a product line extension 'DermaPure Non-Oriented' on Thursday, which it said was specifically tailored for the surgical and trauma markets, further expanding the reach of its flagship 'dCELL' technology product, 'DermaPure'.

Read more
10 Sep 2019 11:26

Tissue Regenix Narrows Interim Loss And Targets Geographic Expansion

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it narrowed its first-half losses as sales rose and expenses were trimmed.In the six months to June 30, group sales, essentially a

Read more
28 Aug 2019 16:00

Mike Barker installed as finance chief at Tissue Regenix

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group announced the appointment of Mike Barker as its chief financial officer on Wednesday.

Read more
28 Aug 2019 13:42

Tissue Regenix Appoints Mike Barker As New Finance Boss

(Alliance News) - Medical devices firm Tissue Regenix Group PLC said Wednesday it appointed Mike Barker as its new chief financial officer with immediate effect.Barker - a chartered - has a

Read more
15 Aug 2019 12:55

Tissue Regenix Expands Manufacturing Capacity To Meet Increased Demand

(Alliance News) - Tissue Regenix Group PLC on Thursday said it has signed a 10-year lease agreement to expand the processing capacity at its manufacturing base in San Antonio, Texas.The the

Read more
15 Aug 2019 09:59

Tissue Regenix signs lease to expand San Antonio facility

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group has signed a 10-year lease agreement on a 21,000 square foot facility, it announced on Thursday, to expand processing capacity at its manufacturing base in San Antonio, Texas.

Read more
1 Aug 2019 15:16

Tissue Regenix Appoints COO Gareth Jones As Interim Chief Executive

(Alliance News) - Tissue Regenix Group PLC said Thursday it has appointed Chief Operating Officer Gareth Jones as interim chief executive with immediate effect.He will be replacing Steve is

Read more
9 Jul 2019 09:26

CORRECT (Jul 8): Woodford Transfers Company Stakes After Omnis Departs

(Correcting that Woodford Investment Management transferred a number of stakes following Omnis's decision. It did not sell these stakes, as was originally reported.)(Alliance News) - of

Read more
20 Jun 2019 16:02

UK Shareholder Meetings Calendar - Next 7 Days

Friday 21 JuneBoohoo GroupGulf KeystoneBH GlobalEJF ResourceSigma

Read more
4 Jun 2019 10:23

Tissue Regenix Reports Strong 2018 Performance; Secures Credit Funding

LONDON (Alliance News) - Medical devices firm Tissue Regenix Group PLC said Tuesday its loss narrowed in 2018, after revenue more than doubled on significant growth in product sales.In a it

Read more
21 May 2019 11:13

Tissue Regenix Chief Executive Couldwell To Return After Medical Leave

LONDON (Alliance News) - Medical devices firm Tissue Regenix Group PLC said on Tuesday that Chief Executive Officer Steve Couldwell will return to his full time duties in June, following a leave a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.